Bosch F - Search Results

1

Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.

Beà S, Ribas M, Hernández JM, Bosch F, Pinyol M, Hernández L, García JL, Flores T, González M, López-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miró R, Campo E. Beà S, et al. Among authors: bosch f. Blood. 1999 Jun 15;93(12):4365-74. Blood. 1999. PMID: 10361135 Free article.

2

PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.

Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, Tassies D, Jaffe ES, Montserrat E, Rozman C, et al. Bosch F, et al. Blood. 1994 Oct 15;84(8):2726-32. Blood. 1994. PMID: 7919385 Free article.

3

p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.

Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E, Raffeld M. Hernandez L, et al. Among authors: bosch f. Blood. 1996 Apr 15;87(8):3351-9. Blood. 1996. PMID: 8605352 Free article.

4

Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.

Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A. Jares P, et al. Among authors: bosch f. Am J Pathol. 1996 May;148(5):1591-600. Am J Pathol. 1996. PMID: 8623927 Free PMC article.

5

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.

Bosch F, López-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA, Vallespí T, Woessner S, Montserrat E. Bosch F, et al. Cancer. 1998 Feb 1;82(3):567-75. doi: 10.1002/(sici)1097-0142(19980201)82:3<567::aid-cncr20>3.0.co;2-z. Cancer. 1998. PMID: 9452276

6

c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.

Hernández L, Hernández S, Beà S, Pinyol M, Ferrer A, Bosch F, Nadal A, Fernández PL, Palacín A, Montserrat E, Campo E. Hernández L, et al. Among authors: bosch f. Leukemia. 1999 Dec;13(12):2087-93. doi: 10.1038/sj.leu.2401599. Leukemia. 1999. PMID: 10602433

7

Polycythaemia vera following non-Hodgkin's lymphoma.

Bosch F, Cervantes F, Lopez-Guillermo A, Carreras E, Montserrat E, Rozman C. Bosch F, et al. Leuk Lymphoma. 1992 Dec;8(6):501-2. doi: 10.3109/10428199209051034. Leuk Lymphoma. 1992. PMID: 1297483

8

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

López-Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E, Rozman C. López-Guillermo A, et al. Among authors: bosch f. J Clin Oncol. 1994 Jul;12(7):1343-8. doi: 10.1200/JCO.1994.12.7.1343. J Clin Oncol. 1994. PMID: 8021724

9

PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.

Jares P, Fernández PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A. Jares P, et al. Among authors: bosch f. Cancer Res. 1994 Sep 1;54(17):4813-7. Cancer Res. 1994. PMID: 8062283

10

Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.

Campo E, Miquel R, Jares P, Bosch F, Juan M, Leone A, Vives J, Cardesa A, Yague J. Campo E, et al. Among authors: bosch f. Cancer. 1994 Jun 15;73(12):2913-21. doi: 10.1002/1097-0142(19940615)73:12<2913::aid-cncr2820731207>3.0.co;2-l. Cancer. 1994. PMID: 8199988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,519 results

Search Page

Filters